Characteristics of Glargine in Type 2 Diabetics

Clinical trial NCT00574912 · COMPLETED

Trial details

NCT number: NCT00574912
Sponsor: Vanderbilt University Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2007-03-01
Primary completion: 2009-09-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.